RevBio, Inc.: RevBio Receives Approval to Start a Dental Clinical Trial in Italy for its Regenerative Biomaterial

This Study Will Help Assess the Time Necessary for Tetranite to Regenerate Bone in the Oral Environment RevBio, Inc., announced that it has received approval from the Italian Ministry of Health and

Related Keywords

Italy ,United States ,Chieti ,Abruzzo ,Italian ,Revbio Tetranite ,Dannunzio Chieti Pescara ,Gianmaria Daddazio ,Maurizio Piattelli ,Manlio Santilli ,Bruna Sinjari ,Michael Tiedemann ,Sergio Caputi ,Kostenloser Wertpapierhandel ,Paul Fugazzotto ,Ethics Committee Of The Universityg Dannunzio ,Italian Ministry Of Health ,University Of Chieti ,Revbio Inc ,Provost Of The University ,Department Of Innovative Technologies In Medicine ,Study Will Help Assess ,Time Necessary ,Regenerate Bone ,Italian Ministry ,Ethics Committee ,Business Wire ,Advanced Studies ,Professor Sergio Caputi ,Professor Maurizio Piattelli ,Tonino Traini ,Gianmariad Addazio ,Innovative Technologies ,Revbio ,Eceives ,Approval ,Start ,Ental ,Linical ,Trial ,Regenerative ,Biomaterial ,